Testing effectiveness (Phase 2)Study completedNCT00002965
What this trial is testing
Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
Who this might be right for
Brain and Central Nervous System Tumors
M.D. Anderson Cancer Center 16